BRIGHT MINDS BIOSCIENCES INC.

DRUG · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.9B · 25 employees
84
SEC Filings
$67.6
Close 2026-07-02
25
Employees

Business Summary

Bright Minds Biosciences Inc. is a biotechnology company developing innovative treatments for neurological and psychiatric disorders. Its pipeline includes novel serotonergic agonists targeting 5-HT2C and 5-HT2A receptor subtypes. Lead product BMB-101 is a 5-HT2C selective agonist in Phase 2 clinical trials for drug-resistant epilepsies including Dravet Syndrome. Other candidates BMB-201 and BMB-202 are selective 5-HT2A agonists in IND-enabling studies for neuropsychiatry and neurology indications.

Latest Stock Quote

DRUG 2026-07-02 $67.6 O:$67 H:$69.5 L:$65.83 Vol:0.2M VWAP:$67.3694
origin leaf: null

84 total filings indexed. 84 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

epilepsy depression neuropsychiatry central-nervous-system-(cns)-disorders opioid-use-disorder pain-disorders binge-eating-disorder alzheimer's-disease 5-ht2c-selective-agonism 5-ht2a-selective-agonism biased-agonism-(gq-protein-signaling-pathway) structure-based-drug-design high-throughput-screening bret-(bioluminescence-resonance-energy-transfer)-assays quantitative-electroencephalogram-(qeeg)

Company Identity

CIK0001827401
TickerDRUG
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedA1
HeadquartersNew York, NY
Websitehttps://www.brightmindsbio.com
Listed2021-03-08

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 45ce1f6855704b929eda3c1fcd10374a3e4bc3c0a09a9dd4646abc21c27ce260
parent: root
content hash: 2844475bd574bff8c3ed111565b0ad8d62e258f02c3100f203aa3cff92e062e0
signed: 2026-08-11T12:02:01.067Z
sources: 0 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up DRUG using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on DRUG, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/DRUG (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.